| 000 | 01108 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250511205606.0 | ||
| 264 | 0 | _c19910604 | |
| 008 | 199106s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/27.suppl_a.11 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOlsson-Liljequist, B | |
| 245 | 0 | 0 |
_aIn-vitro activity of clarithromycin combined with its 14-hydroxy metabolite A-62671 against Haemophilus influenzae. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cFeb 1991 |
||
| 300 |
_a11-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aClarithromycin |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xpharmacology |
| 650 | 0 | 4 |
_aErythromycin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aHaemophilus influenzae _xdrug effects |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 700 | 1 | _aHoffman, B M | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 27 Suppl A _gp. 11-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/27.suppl_a.11 _zAvailable from publisher's website |
| 999 |
_c1833303 _d1833303 |
||